Grants announcements from the MassGeneral Hospital for Children Research Council.
Announcement: New Biographical Sketch Format Required for NIH and AHRQ Grant Applications Submitted for Due Dates on or after January 25th, 2015
The revised forms and instructions are now available on the SF 424 (R&R) Forms and Applications page.
MassGeneral Hospital for Children
Request for Proposals for Pilot Feasibility Studies
Deadline: April 15th, 2015
The MassGeneral Hospital for Children (MGHfC) is accepting applications for awards to support clinical or laboratory-based pilot feasibility studies. The intent of the awards is to allow MGHfC junior faculty who lack other substantial sources of research support to initiate studies that have a high likelihood of leading to extramural funding.
AWARD DESCRIPTION AND CRITERIA
1. Upto 2 proposals will be awarded $20,000 each to be used over 1 year for supplies and support staff salaries. The awards cannot be used to cover salary for the Principal Investigator (applicant) or equipment. Indirect costs are not allowed.
2. The applicant should hold the rank of Instructor or Assistant Professor, and should play an active role in the care of pediatric patients and/or the research activities of the MGHfC. He or she should not have significant independent funding from other sources. Investigators with NIH K awards are eligible, but those with R awards are not.
3. The deadline for receipt of applications is 12 noon on April 15th, 2015.
4. The award will be announced in June, with funding expected to start by July 1st.
5. Selection criteria for the awards will include the applicant’s record of achievements and commitment to research, the scientific merits of the proposal, and the likelihood that the project will lead to long-term funding.
The application should include all the components listed below:
1. Partners cover-page with signatures of the Principal Investigator and Division Chief.
2. Description of proposed research, including Aims, Background and Significance, Preliminary Data (if available) and Experimental Design (5 pages maximum for these items). Literature citations are not included in the page limit.
3. Budget, including a brief justification of the expenses.
4. Biosketch of applicant in NIH format (either the old or new format is acceptable).
5. A list of all current and pending research support (including departmental start-up funds, if any), with dates of awards, direct cost dollar amounts, goals, and overlap, if any, with current proposal.
6. Copy of IRB or IACUC approval if applicable.
7. Two letters of support - from a research mentor and the Division Chief. In addition to an evaluation of the applicant’s qualifications for the award, the letters should indicate plans for his or her career development, and the amount of protected time devoted to research.
Components 2 to 5 should be formatted according to NIH guidelines using pages with no less than 0.5” margins, Arial font, no smaller than 11 point (figures and legends may use smaller font as long as it is legible), single-spaced. Page restrictions are inclusive of figures, tables and other pertinent data, and will be strictly enforced. Assemble all components of the application into a single PDF file in the order indicated, and e-mail to Suzzette McCarron (firstname.lastname@example.org). Address any questions to Dr. Bobby Cherayil (email@example.com).
Gerstner Scholar Award in ADHD Research
Two-year competitive award for MD- and PhD-level junior faculty who are within five years of completing training. Qualified applicants will have a demonstrated interest in ADHD and related co-morbidities as shown through past projects and publications. Applications on ADHD plus substance use disorders are particularly encouraged.
Applicants must have faculty appointments at Massachusetts General Hospital (MGH).
Awards will be for $60,000 per year and may be used for an original research project or to broaden or supplement an existing project. Funding may be used for direct salary and fringe support of the Scholar or for related costs such as research assistant time/effort, biostatistical services, neuroimaging, genetic analysis and travel to scientific meetings.
Indirect costs to the MGH (15%) not to exceed 9,000$/year are to be paid by the sponsor/ mentor’s laboratory
Scholars will conduct clinical or translational research related to ADHD (plus comorbidity).
Scholars will spend at least 50 percent of their time in the conduct of clinical research.
Scholars will be mentored by senior faculty at the MGH with ADHD expertise.
Application requirements will include:
- Application form
- One-page statement of applicant’s research interests
- One-page budget
- Applicant’s curriculum vitae
- Letter of support by MGH mentor
- Additional letter of support if a co-mentor or co-investigator is involved in the project
- February 17, 2015: Application deadline
- March 9, 2015: Announcement of 2015-2016 Gerstner Research Scholars
- July 1, 2015: Award Program Year 1 begin
For information, contact Timothy Wilens, MD (firstname.lastname@example.org). All information can be sent electronically via email to Dr. Wilens; or in hard copy to Dr. Wilens c/o Yawkey 6A, MGH.
MGH-MIT Grand Challenge 3: Neuroscience
Grand Challenge 3: Develop joint ventures which link basic and clinical research in order to accelerate progress towards more effective diagnostic approaches and therapies in clinical neuroscience.
Award Types and Amounts:
Note: Each award amount represents total award, inclusive of IDC/fund fees, 10% at MIT and 15% at MGH.
Letter of Intent (LOI): To be eligible to apply for this award, you must submit an e-mail notification with a letter of intent to apply as well as an award coversheet by February 6, 2015. Letters of intent should include the attached cover sheet, the names of the principal investigators and a brief description of the project. Please submit the LOI and coversheet to imes_rfp@email@example.com AND to firstname.lastname@example.org.
The email subject should read “MIT-MGH Challenge 3” and should include a single pdf file with the following name convention: the PI(s) last name separated by “_” and followed by “_LOI_GC3”.
Selected LOI will receive an email inviting a full proposal and detailed submission instructions.
Full Proposal Submission Date: March 15, 2015
Project Start Date: June 1, 2015
To view the complete RFA, please click here.
MGH ECOR Formulaic Bridge Funding
What is it? Formulaic Bridge Funding Support is offered to assist MGH Principal Investigators during a lapse or delay in their funding from NIH. To be eligible for Formulaic Bridge Funding, applicants must have applied as a PI for an R01 or R21 grant to support an independent, long-term research program.
The Formulaic Bridge process is open to:
1. Investigators whose grants received a score < or = 20th percentile and have received written communication from the NIH that the grant will not be funded.
2. Investigators whose grants received a fundable score (< or = 20th percentile) but are 3 months past the nominal start date of the the grant.
When is the deadline? 7th day of each month.
Harvard CFAR Feasibility Projects and Scholar Awards
The Harvard University Center for AIDS Research (HU CFAR) is pleased to announce a Request for Proposals for HIV/AIDS research for awards beginning April 1, 2015.
The HU CFAR welcomes proposals for Feasibility Projects and Scholar Awards for research in all disciplines, including but not limited to, one or more of the following:
Download complete application PDF
Applications are due February 2, 2015
at 4 PM
Pfizer Centers for Therapeutic Innovation 2015
CTI supports translational programs in the therapeutic areas of Inflammation, Autoimmunity, Tissue remodeling, Oncology, Cancer immunotherapy, Rare or genetic diseases, Neuroscience, Cardiovascular and metabolic diseases.
CTI now has three annual Call-for-Proposal deadlines. The 2015 submission deadlines for a 2 page pre-proposal are February 13, June 12 and October 16.
Researchers working with validated drug targets that are tractable with biologic modalities such as antibodies, peptides, proteins, and are interested in developing a novel therapeutic agent to address an unmet clinical need should apply.Pfizer may fund 1-3 post-doctoral fellows for 2-3 years per project. Any intellectual property covering the newly developed therapeutic will be jointly owned by the Partners entity and CTI. Background intellectual property is not necessary for submission, but access to it may be required, if it exists.
The process: Pre-proposals should be submitted via email to Partners Innovation. Innovation will conduct a review of each pre-proposal to ensure that no confidential or proprietary information is included, prior to forwarding to CTI. CTI will make the decisions on which pre-proposals to advance to a full proposal stage. Invitations will then be sent to the PI‘s to submit confidential full proposals, to be developed together with CTI personnel. Funding decisions on full proposals will be made by the CTI-Partners Joint Steering Committee.
If you have any questions regarding the program, please contact Rekha Paleyanda at email@example.com.
HMS Foundation Funds
The Fall nomination process for the 2014 HMS Foundation Funds is complete. Please see the website for further details.
If you are an MGH investigator, you should not apply directly to HMS for several of the funding opportunities offered through the HMS foundation funds annually. Please see the chart located here to determine where to apply and for information on the process.
If you have any questions, please contact Erin McGivney at 617-643-6471.
Limited Submission Funding Opportunities
We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to firstname.lastname@example.org. In addition to your LOI, please include an NIH Biosketch.
The letter of intent should include:
- Name of the Principal Investigator with appropriate contact information
- A descriptive title of the potential application
- Brief description of the project
- Brief description of why you specifically should be selected to receive institutional nomination for this award
In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.
Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.
- Centers for Common Disease Genomics (UM1)
- Centers for Mendelian Genomics (UM1)
- Environmental Health Sciences Core Centers (EHS CC) (P30)
- NIAMS Skin Biology and Diseases Resource-based Centers (P30)
- NIAMS Rheumatic Diseases Research Resource-based Centers (P30) - NEW!
If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.
Private Funding Opportunities
Please contact Corporate & Foundation Relations in the Office of Development at email@example.com if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.
- Shark Tank Competition, Epilepsy Foundation of America (EFA)
Please click here for further details on these funding opportunities.
Please click here to find current grant opportunities from the Patient-Centered Outcomes Research Institute.
NIH Funding Opportunities
For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm